Vaginal Infection (Treatment)

Clearer Labeling Needed For OTC Vaginal Antifungals

Published in Women's Health Weekly, October 5th, 1998

Women need more guidance on using over-the-counter (OTC) treatments for vaginal yeast infections, said the U.S. Food and Drug Administration's (FDA) Nonprescription Drugs Advisory Committee on September 25, 1998.

The panel said women seem to be confused by current labeling, and that many are self-diagnosing, which could lead to other health problems.

The products, including miconazole, clotrimazole, and butoconazole, are supposed to be used only when women have had an infection previously diagnosed by a physician. But the FDA said a recent survey by Prevention magazine found that 45 percent of women were self-diagnosing with initial use of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-10-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry